Preface |
|
xv | |
Contributors |
|
xvii | |
|
Overview: Handbook of Pharmaceutical Analysis by HPLC |
|
|
|
|
|
1 | (2) |
|
|
3 | (1) |
|
HPLC Instrumentation in Pharmaceutical Analysis |
|
|
3 | (1) |
|
HPLC Columns in Pharmaceutical Analysis |
|
|
4 | (1) |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
How to be More Successful with HPLC Analysis |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
Assay and Stability Testing |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
11 | (1) |
|
High-throughput Screening |
|
|
11 | (1) |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
14 | (2) |
|
Chromatography Data Processing |
|
|
16 | (1) |
|
|
16 | (4) |
|
|
16 | (4) |
|
Key Concepts of HPLC in Pharmaceutical Analysis |
|
|
|
|
|
|
20 | (1) |
|
|
20 | (2) |
|
|
22 | (13) |
|
|
35 | (4) |
|
Isocratic Vs. Gradient Analysis |
|
|
39 | (4) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (4) |
|
|
44 | (1) |
|
|
44 | (4) |
|
HPLC Instrumentation in Pharmaceutical Analysis: Status, Advances, and Trends |
|
|
|
|
|
48 | (1) |
|
|
48 | (2) |
|
HPLC Solvent Delivery Systems |
|
|
50 | (8) |
|
|
58 | (1) |
|
|
59 | (3) |
|
|
62 | (1) |
|
UV/Vis Absorbance Detectors |
|
|
62 | (3) |
|
Photodiode Array (PDA) Detectors |
|
|
65 | (2) |
|
|
67 | (2) |
|
|
69 | (1) |
|
Instrumental Bandwidth (IBW) |
|
|
69 | (3) |
|
Instrumentation Trends in Pharmaceutical Analysis |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
73 | (5) |
|
|
73 | (1) |
|
|
73 | (4) |
|
HPLC Columns for Pharmaceutical Analysis |
|
|
|
|
|
|
|
|
|
|
|
77 | (1) |
|
|
78 | (1) |
|
|
78 | (19) |
|
|
97 | (22) |
|
|
119 | (1) |
|
|
120 | (3) |
|
Sample Preparation for HPLC Analysis of Drug Products |
|
|
|
|
|
|
123 | (1) |
|
|
124 | (1) |
|
Sample Preparation Overview |
|
|
125 | (8) |
|
Primary SP Concerns for Types of Analysis |
|
|
133 | (1) |
|
Sample Preparation Trends in Pharmaceutical Analysis |
|
|
134 | (1) |
|
|
135 | (7) |
|
|
142 | (4) |
|
|
142 | (1) |
|
|
143 | (2) |
|
|
|
|
|
|
|
|
145 | (1) |
|
|
146 | (1) |
|
Phase-Appropriate Method Development |
|
|
147 | (2) |
|
Proactive Method Development |
|
|
149 | (10) |
|
Development, Validation, and Use of Early Phase Methods |
|
|
159 | (7) |
|
Final Method Development and Validation |
|
|
166 | (21) |
|
|
187 | (5) |
|
|
188 | (1) |
|
|
188 | (4) |
|
Validation of HPLC Methods in Pharmaceutical Analysis |
|
|
|
|
|
192 | (1) |
|
|
192 | (2) |
|
Validation Requirements for Method Type |
|
|
194 | (2) |
|
|
196 | (1) |
|
|
197 | (14) |
|
Method Validation by Phase of Development |
|
|
211 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (2) |
|
Method-Validation Software |
|
|
215 | (1) |
|
|
216 | (3) |
|
|
216 | (1) |
|
|
216 | (3) |
|
|
|
|
|
219 | (1) |
|
|
219 | (1) |
|
Ion Chromatography Instrumentation |
|
|
220 | (1) |
|
Chromatographic Components |
|
|
221 | (27) |
|
Pharmaceutical Ion Chromatography Applications |
|
|
248 | (5) |
|
|
253 | (3) |
|
|
253 | (1) |
|
|
253 | (2) |
|
How to Be More Successful with HPLC Analysis: Practical Aspects in HPLC Operation |
|
|
|
|
|
255 | (1) |
|
|
256 | (1) |
|
|
256 | (3) |
|
HPLC Pump-operating Guides |
|
|
259 | (1) |
|
HPLC Column-operating Guides |
|
|
259 | (1) |
|
Detector-operating Guides |
|
|
260 | (1) |
|
Autosampler-operating Guides |
|
|
261 | (1) |
|
Quantitation-operating Guides |
|
|
262 | (1) |
|
System Shutdown-operating Guides |
|
|
263 | (1) |
|
Summary of HPLC Operation |
|
|
263 | (1) |
|
|
263 | (2) |
|
|
265 | (4) |
|
|
269 | (4) |
|
|
270 | (1) |
|
|
270 | (3) |
|
Regulatory Considerations in HPLC Analysis |
|
|
|
|
|
|
273 | (1) |
|
|
273 | (1) |
|
Chromatography---Some Generalities |
|
|
274 | (2) |
|
Validation of Chromatographic Methods |
|
|
276 | (10) |
|
|
286 | (4) |
|
Overview of Available Guidance Documents |
|
|
290 | (1) |
|
|
290 | (1) |
|
|
290 | (1) |
|
HPLC System Calibration for GMP Compliance |
|
|
|
|
|
291 | (1) |
|
|
291 | (1) |
|
Overall Calibration Strategies |
|
|
292 | (1) |
|
Calibration Procedure: A Case Study |
|
|
293 | (6) |
|
Overall Procedures and Documentation |
|
|
299 | (1) |
|
|
300 | (4) |
|
|
301 | (1) |
|
|
301 | (2) |
|
System Validation: Pre-Installation, IQ, OQ, and PQ |
|
|
|
|
|
303 | (1) |
|
Introduction: What is Validation, and Why Validate? |
|
|
304 | (1) |
|
|
304 | (1) |
|
|
305 | (4) |
|
|
309 | (14) |
|
|
323 | (9) |
|
|
332 | (4) |
|
|
333 | (1) |
|
|
333 | (2) |
|
Assay and Stability Testing |
|
|
|
|
|
|
335 | (1) |
|
|
336 | (2) |
|
Stability Program in Pharmaceutical Development |
|
|
338 | (8) |
|
Stability Testing by HPLC |
|
|
346 | (11) |
|
|
357 | (2) |
|
|
357 | (1) |
|
|
358 | (1) |
|
|
|
|
|
|
359 | (1) |
|
|
359 | (4) |
|
Drug Substance Evaluation |
|
|
363 | (12) |
|
Impurities in Dosage Forms |
|
|
375 | (2) |
|
|
377 | (3) |
|
|
377 | (1) |
|
|
377 | (2) |
|
HPLC in Dissolution Testing |
|
|
|
|
|
|
379 | (1) |
|
|
380 | (3) |
|
Utility of HPLC Analysis in Dissolution Testing |
|
|
383 | (2) |
|
Considerations of HPLC Methods in Dissolution Testing |
|
|
385 | (5) |
|
HPLC in Automated and Robot-Assisted Dissolution Testing |
|
|
390 | (6) |
|
Requirements of HPLC Methods for Dissolution Testing During Drug Development Process |
|
|
396 | (2) |
|
|
398 | (3) |
|
|
399 | (1) |
|
|
399 | (2) |
|
Cleaning Validation using HPLC for Analysis |
|
|
|
|
|
401 | (1) |
|
|
401 | (1) |
|
|
402 | (1) |
|
Linearity, Detection and Quantitation |
|
|
403 | (1) |
|
Validation of Rinse and Swabbing Procedures |
|
|
404 | (3) |
|
Recovery Studies off Surfaces |
|
|
407 | (3) |
|
Verification of the Cleaning Procedure |
|
|
410 | (1) |
|
Verifying the Removal of Cleaning Agents |
|
|
410 | (1) |
|
|
411 | (3) |
|
|
412 | (1) |
|
|
412 | (1) |
|
LC/MS Application in High-Throughput ADME Screen |
|
|
|
|
|
413 | (1) |
|
|
414 | (1) |
|
Measurement of Physicochemical Properties |
|
|
415 | (9) |
|
Cytochrome P450 Inhibition Assay |
|
|
424 | (3) |
|
|
427 | (3) |
|
|
430 | (2) |
|
|
432 | (6) |
|
|
438 | (10) |
|
|
439 | (1) |
|
|
439 | (8) |
|
|
|
|
|
|
|
|
447 | (1) |
|
|
448 | (5) |
|
Separation of Enantiomers of Pharmaceutical Interest Using LC and CE |
|
|
453 | (4) |
|
Separation of Enantiomers by Capillary Electrophoresis |
|
|
457 | (6) |
|
Separation of Enantiomers by Liquid Chromatography on Chiral Stationary Phases |
|
|
463 | (20) |
|
Practical Guidelines to Chiral HPLC Separations of Pharmaceuticals |
|
|
483 | (5) |
|
|
488 | (12) |
|
|
489 | (11) |
|
Applications of LC/MS in Pharmaceutical Analysis |
|
|
|
|
|
500 | (1) |
|
|
500 | (3) |
|
|
503 | (11) |
|
|
514 | (4) |
|
Practical Considerations in Selection of LC/MS Parameters |
|
|
518 | (8) |
|
Peak Tracking Between LC/UV and LC/MS Methods |
|
|
526 | (2) |
|
Development of Generic LC/MS Method and LC/MS Database |
|
|
528 | (7) |
|
MS-Assisted HPLC Method Development and Validation |
|
|
535 | (6) |
|
Impurity Profiling for Drug Substances and Pharmaceutical Products |
|
|
541 | (12) |
|
Supporting Marketed Drug Products |
|
|
553 | (11) |
|
|
564 | (6) |
|
|
565 | (1) |
|
|
565 | (4) |
|
Application of LC-NMR in Pharmaceutical Analysis |
|
|
|
|
|
569 | (1) |
|
|
570 | (1) |
|
Instrumentation and Design |
|
|
571 | (2) |
|
|
573 | (3) |
|
Related Hyphenated Techniques |
|
|
576 | (2) |
|
|
578 | (4) |
|
|
578 | (3) |
|
Chromatography Data Systems (CDS) in the Pharmaceutical Laboratory: Its History, Advances, and Future Direction |
|
|
|
|
|
581 | (1) |
|
|
582 | (1) |
|
A Historical Look at CDS Development |
|
|
582 | (6) |
|
|
588 | (14) |
|
Specific Needs of the Pharmaceutical Industry |
|
|
602 | (6) |
|
|
608 | (3) |
|
|
609 | (1) |
|
|
609 | (2) |
|
|
|
|
|
|
611 | (1) |
|
|
611 | (1) |
|
Simplifying Sample Preparation |
|
|
612 | (2) |
|
|
614 | (1) |
|
Improvements in Detectors |
|
|
615 | (1) |
|
Improvements in HPLC Throughput |
|
|
616 | (11) |
|
|
627 | (4) |
|
|
628 | (1) |
|
|
628 | (3) |
Index |
|
631 | |